NEONATAL INCONTINENTIA PIGMENTI – A CASE REPORT
Keywords:
incontinentia pigmenti, erythematous linear vesicles, Bloch- Sulzberger syndromeAbstract
Incontinentia pigmenti or Bloch-Sulzberger syndrome, is a rare multisystem, X-linked dominant disorder that most commonly occurs in female newborns. It is usually lethal, and most pregnancies with male fetuses result in miscarriage or stillbirth, while in female newborns, it can appear with different severity and multiorgan symptoms, including dermatological, neurological, ophthalmological, and dental abnormalities. Skin changes usually appear immediately after birth or in the first few weeks of life, following four stages: vesicular, verrucous, hyperpigmented, and hypopigmented. In the neonatal period, IP is clinically diagnosed based on the appearance of vesicles arranged in a linear pattern following Blaschko’s lines, representing the first stage of skin involvement. The differential diagnosis of a vesicular eruption in a neonate is extensive and includes various infectious and non-infectious causes.
We report a case of a one-day-old female neonate who presented at birth with erythematous vesicles linearly distributed on the extremities, over the thorax and abdomen. Based on suspicious Blaschkoid skin lesions and eosinophilic skin infiltration in biopsy, incontinentia pigmenti was diagnosed.
Early recognition of IP is crucial for appropriate management and monitoring of potential complications, particularly those involving the central nervous system and eyes. Although there is no specific cure for IP, a multidisciplinary approach involving dermatologists, neurologists, ophthalmologists, and dentists can help optimize the quality of life of affected infants.
References
Landy SJ, Donnai D. Incontinentia pigmenti (Bloch Sulzberger syndrome). J Med Genet. 1993;30(1):53–9. doi:10.1136/jmg.30.1.53
Okan F, Yapici Z, Bulbul A. Incontinentia pigmenti mimicking a herpes simplex virus infection in the newborn. Childs Nerv Syst. 2008;24(1):149–51. doi:10.1007/s00381-007-0406-6
Ardelean D, Pope E. Incontinentia pigmenti in boys: a series and review of the literature. Pediatr Dermatol. 2006;23(6):523–7.
Hadj-Rabia S, Rimella A, Smahi A, et al. Clinical and histologic features of incontinentia pigmenti in adults with nuclear factor κB essential modulator gene mutations. J Am Acad Dermatol. 2011;64(3):508–15.
Hadj-Rabia S, Rimella A, Smahi A, et al. Clinical and histologic features of incontinentia pigmenti in adults with nuclear factor κB essential modulator gene mutations. J Am Acad Dermatol. 2011;64(3):508–15.
Minić S, Trpinac D, Obradović M. Incontinentia pigmenti diagnostic criteria update. Clin Genet. 2014;85(6):536–42. doi:10.1111/cge.12223
Fryssira H, Kakourou T, Valari M, et al. Incontinentia pigmenti revisited. A novel nonsense mutation of the IKBKG gene. Acta Paediatr. 2011;100(1):128–33.
Shah L, Balakumar G. Visual diagnosis: a persistent newborn rash. Pediatr Rev. 2007;28(11):429–32.
Taborda ABV, Fonseca J, Ruas E, et al. Incontinência pigmenti: caso clínico. Acta Pediatr Port. 1999;30:499–502.
Pacheco TR, Levy M, Collyer JC, et al. Incontinentia pigmenti in male patients. J Am Acad Dermatol. 2006;55(2):251–5.
Ventura L, Silva I, Carreiro H, et al. [Incontinentia pigmenti in 2 newborn infants]. Pediatrie. 1988;43:223–5.
Hadj Rabia S, Froidevaux D, Bodak N, et al. Clinical study of 40 cases of incontinentia pigmenti. Arch Dermatol. 2003;139(9):1163–70.
Lerer RJ, Ehrenkranz RA, Campbell AG. Pigmented lesions of incontinentia pigmenti in a neonate. J Pediatr. 1973;83(3):503–5.
Faloyin M, Levitt J, Bercowitz E, et al. All that is vesicular is not herpes: incontinentia pigmenti masquerading as herpes simplex virus in a newborn. Pediatrics. 2004;114(2):e270–2. doi:10.1542/peds.114.2.e270
Drolet BA, Esterly NB. The skin. In: Fanaroff AA, ed. Neonatal Perinatal Medicine: Diseases of the Fetus and Infant. 7th ed. St Louis, MO: Mosby; 2002. p.1537.
Machado Pinto J, McCalmont TH, Golitz LE. Eosiniphilic and Neutrophilic Spongiosis: Clues to the Diagnosis of Immunobullous Diseases and Other Inflammatory Disorders. Semin Cut Med Surg. 1996;15(4):308–16.
Jean Baptiste S, O’Toole EA, Chen M, et al. Expression of eotaxin, an eosinophil selective chemokine, parallels eosinophil accumulation in the vesiculobullous stage of incontinentia pigmenti. Clin Exp Immunol. 2002;127(3):470–8.
